Drug Trial Radar · NCT00147719
WelChol® With Metformin in Treating Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Jan 18, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jun 2004
Primary completion
Jul 2006
Study completion Jul 2006
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Sep 7, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
Conditions
- Type 2 Diabetes
Interventions
Colesevelam hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the additional lowering of HbA1C achieved by addition of colesevelam hydrochloride to current antidiabetic therapy
Locations
48 sites in 3 countries. Site status is shown where the registry gives one.
CRO
Jonesboro, Arkansas
Site not named
Beverly Hills, California
Site not named
Carmichael, California
Site not named
Fresno, California
Site not named
Irvine, California
Site not named
La Jolla, California
Site not named
Los Gatos, California
Site not named
San Diego, California
Site not named
Spring Valley, California
Site not named
West Hills, California
Site not named
Washington D.C., District of Columbia
Site not named
Coco Beach, Florida
Site not named
Largo, Florida
Site not named
Miami, Florida
Site not named
Pembroke Pines, Florida
Site not named
West Palm Beach, Florida
Site not named
Atlanta, Georgia
Site not named
Evansville, Indiana
Site not named
Louisville, Kentucky
Site not named
Detroit, Michigan
Site not named
Troy, Michigan
Site not named
Edina, Minnesota
Site not named
Chesterfield, Missouri
Site not named
Bozeman, Montana
Site not named
Butte, Montana
Site not named
Las Vegas, Nevada
Site not named
Rochester, New York
Site not named
Charlotte, North Carolina
Site not named
Winston-Salem, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Cleveland, Ohio
Site not named
Lyndhurst, Ohio
Site not named
Marion, Ohio
Site not named
Oklahoma City, Oklahoma
Site not named
Tulsa, Oklahoma
Site not named
Portland, Oregon
Site not named
Beaver, Pennsylvania
Site not named
Charleston, South Carolina
Site not named
Columbia, South Carolina
Site not named
Morristown, Tennessee
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.